Global pharma giant GlaxoSmithKline Pharmaceuticals Ltd received an income tax refund of ₹222.23 crore for the assessment year 2022-23, following an order issued by the Income Tax Department on Tuesday.
Global healthcare major informed in regulatory filings of an Income Tax Order for Assessment Year 2022-23 issuing income tax refund of Rs 222.23 cr including interest.
GlaxoSmithKline Pharmaceuticals declared a 37.8% year-on-year (YoY) increase in net profit to Rs.182.3 crore in the first quarter ended June 30, 2024. GlaxoSmithKline’s net profit in the same quarter was Rs.132.3 crore while revenue rose by 7% to Rs.814.7 crore from Rs.761.7 crore in the same period last year
NHAI Seeks Forest Clearance For 14.89 Km Autram Ghat Tunnel Project In Maharashtra
IGNOU ODL January 2026 Application Closes Today: Check Application Process, Documents Needed & Fee Details Here
Another Setback For Jana Nayagan: Thalapathy Vijay's Film Faces Further Delay Amid CBFC Row, Won't Release Before April
Bank Holidays In February 2026, Will Banks Remain Closed For 3 Consecutive Days?
